The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

In addition, in the coming years, oral GLP-1 receptor agonists and injectable formulations that require less-frequent ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

At this time, there are no recommendations to adjust the dose of GLP-1 medications when also taking birth control. Other Oral Medications GLP-1 agonists may affect how other medications taken by ...

Depending on the medication, the effects can last for a minimum of 24 hours to a few weeks. Examples include dulaglutide, ...

Pfizer executives are still bullish on the opportunity for its own obesity and diabetes drugs under development, eyeing a potential opening for oral versions and an improved safet ...

This drug class, involving injectable and oral medications used for weight-loss ... of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

But patients taking GLP-1 drugs did have a greater likelihood of retained gastric contents and of aborted upper endoscopies, ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...